Myocarditis and Pericarditis After mRNA COVID-19 Vaccination: 2024 Status and Management Update.

McDonald, Michael A; Kafil, Tahir S; Khoury, Michael; Luk, Adriana C; Wright, Meredith K; Hawkins, Nathaniel M

McDonald, Michael A; Kafil, Tahir S; Khoury, Michael; Luk, Adriana C; Wright, Meredith K; Hawkins, Nathaniel M.

Affiliation

McDonald MA; Division of Cardiology, Peter Munk Cardiac Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: michael.mcdonald@uhn.ca.
Kafil TS; Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Khoury M; Division of Cardiology, Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.
Luk AC; Division of Cardiology, Peter Munk Cardiac Centre, University of Toronto, Toronto, Ontario, Canada.
Wright MK; Canadian Cardiovascular Society, Ottawa, Ontario, Canada.
Hawkins NM; Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Can J Cardiol ; 40(9): 1536-1540, 2024 Sep.

Article de En | MEDLINE | ID: mdl-38537672

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Péricardite / Vaccins contre la COVID-19 / COVID-19 / Myocardite Limites: Humans Langue: En Journal: Can J Cardiol Sujet du journal: CARDIOLOGIA Année: 2024 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google